JB

Jyoti Bhojagarhia

Active Director Director DIN 07561921
DIN 07561921 First appointment Jul 2016 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Jul 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Jyoti Bhojagarhia

Data last updated:

Jyoti Bhojagarhia is a Director at Numerone Pharma Private Limited (since 2016) and Partner at Padmika Projects Llp (since 2020). The companies operate in Pharma, Real Estate and Construction and Infrastructure and Utilities. The largest current company by reported revenue is Numerone Pharma Private Limited at ₹11.3 Lakh (FY 2020). Earlier, Jyoti Bhojagarhia was an Additional Director at Padmika Projects Limited (2017–2020) and Director at Sky Brass Art Private Limited (from 2017) and 3 more.

DIN 07561921
Primary Designation Director
Industry Pharma
First Appointment 29 Jul 2016
Oldest Company Age 22 yrs
Largest company Numerone Pharma Private Limited Β· ₹11.3 Lakh (FY 2020)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Numerone Pharma Private Limited U74999MH2016PTC284233
Director29 Jul 20162016₹11.3 Lakh (FY 2020)Active
Partner25 Sep 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Padmika Projects Limited U70102WB2014PLC201297
Additional Director03 Mar 20172014₹2.1 Lakh (FY 2019)Converted To Llp
Sky Brass Art Private Limited U20296DL2007PTC168202
Director27 Jun 20172007₹25,000 (FY 2019)Amalgamated
Neel Kanth Candle Private Limited U24248DL2007PTC168996
Director27 Jun 20172007₹39,040 (FY 2019)Amalgamated
Sailaja Construction Private Limited U45209MH2004PTC282155
Director24 Jun 20172004₹33.5 Lakh (FY 2019)Amalgamated
Blackberry Residency Private Limited U45400WB2008PTC123081
Additional Director03 Mar 20172008₹2 Lakh (FY 2019)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Jyoti Bhojagarhia

NameDINCompanyDesignation
Alok Kumar Bhojgarhia05254172Numerone Pharma Private LimitedDirector
Anilkumar Kashiprasad Drolia02354951Padmika Projects LlpDesignated Partner
Reetu Anil Drolia08627279Padmika Projects LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Padmika Projects Llp
Sky Brass Art Private Limited
Neel Kanth Candle Private Limited
Sailaja Construction Private Limited
Premium access

Shareholding and investment profile for Jyoti Bhojagarhia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jyoti Bhojagarhia

Jyoti Bhojagarhia currently holds 2 directorships: Numerone Pharma Private Limited (Director, since 29 Jul 2016, revenue β‚Ή11.3 Lakh (FY 2020)); Padmika Projects Llp (Partner, since 25 Sep 2020).

Jyoti Bhojagarhia was first appointed on 29 Jul 2016 as Director at Numerone Pharma Private Limited. The most recent appointment on record is 25 Sep 2020 at Padmika Projects Llp.

Jyoti Bhojagarhia held 5 earlier board appointments: Padmika Projects Limited (Additional Director, 03 Mar 2017 to 18 Jul 2020); Sky Brass Art Private Limited (Director, from 27 Jun 2017); Neel Kanth Candle Private Limited (Director, from 27 Jun 2017); Sailaja Construction Private Limited (Director, from 24 Jun 2017); Blackberry Residency Private Limited (Additional Director, from 03 Mar 2017).

The current boards of Jyoti Bhojagarhia's companies include Alok Kumar Bhojgarhia (Numerone Pharma Private Limited), Anilkumar Kashiprasad Drolia (Padmika Projects Llp), Reetu Anil Drolia (Padmika Projects Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available